| [3] |
Koenders MI，Van den Berg WB.Novel therapeutic targets in rheumatoid arthritis[J].Trends Pharmacol Sci，2015，36（4）：189-195.
|
| [4] |
Kim EY，Moudgil KD.Immunomodulation of autoimmune arthritis by pro-inflammatory cytokines[J].Cytokine，2017，98：87-96.
|
| [1] |
曹芝艳，于泓.类风湿关节炎治疗研究进展[J].山东医药，2019，59（21）：108-111.
|
| [2] |
于宗良，闫则宇，宋英，等.基于CiteSpace 中药治疗类风湿关节炎的知识图谱分析[J].河南中医，2019，39（9）：1366-1371.
|
| [5] |
Adamopoulos IE，Chao CC，Geissler R，et al.Interleukin-17A upregulates receptor activator of NF-κB on osteoclast precursors[J].Arthritis Res Ther，2010，12（1）：R29.
|
| [6] |
Gizinski AM，Fox DA.T cell subsets and their role in the pathogenesis of rheumatic disease[J].Curr Opin Rheumatol，2014，26（2）：204-210.
|
| [7] |
Alunno A，Carubbi F，Giacomelli R，et al.C ytokines in the pathogenesis of rheumatoid arthritis：new players and therapeutic targets[J].BMC Rheumatol，2017，1：3.
|
| [8] |
Oliver J，Plant D，Orozco G，et al.OP0236 whole transcriptome investigation of response to anti-TNF treatment in rheumatoid arthritis[J].Ann Rheum Dis，2016，75（Suppl 2）：147.
|
| [9] |
Mckenzie AJ，Spits H，Eberl G.Innate lymphoid cells in inflammation and immunity[J].Immunity，2014，41（3）：366-374.
|
| [10] |
Park JK，Han BK，Park JA，et al.CD70-expressing CD4 T cells produce IFN-γ and IL-17 in rheumatoid arthritis[J].Rheumatology（Oxford），2014，53（10）：1896-1900.
|
| [11] |
Kato H，Endres J，Fox DA，et al.The roles of IFN-γ versus IL-17 in pathogenic effects of human Th17 cells on synovial fibroblasts[J].Mod Rheumatol，2013，23（6）：1140-1150.
|
| [12] |
Akitsu A，Ishigame H，Kakuta S，et al.IL-1 receptor antagonist-deficient mice develop autoimmune arthritis due to intrinsic activation of IL-17-producing CCR2（+）Vγ6（+）γδ T cells[J].Nat Commun，2015，6：7464.
|
| [13] |
Noort AR，van Zoest KP，van Baarsen LG，et al.Tertiary lymphoid structures in rheumatoid arthritis：NF-κB-inducing kinase-positive endothelial cells as central players[J].Am J Pathol，2015，185（7）：1935-1943.
|
| [14] |
Leblond A，Allanore Y，Avouac J.Targeting synovial neoangiogenesis in rheumatoid arthritis[J].Autoimmun Rev，2017，16（6）：594-601.
|
| [15] |
Sen R，Baltimore D.Multiple nuclear factors interact with the immunoglobulin enhancer sequences[J].Cell，1986，46（5）：705-716.
|
| [16] |
Hayden MS，Ghosh S.Signaling to NF-κB[J].Genes Dev，2004，18（18）：2195-2224.
|
| [17] |
Sun B，Karin M.NF-κB signaling，liver disease and hepatoprotective agents[J].Oncogene，2008，27（48）：6228-6244.
|
| [18] |
Sun HQ，Yan D，Wang QN，et al.1，25-dihydroxyvitamin D3 attenuates disease severity and induces synoviocyte apoptosis in a concentration-dependent manner in rats with adjuvant-induced arthritis by inactivating the NF-κB signaling pathway[J].J Bone Miner Metab，2019，37（3）：430-440.
|
| [19] |
Iwai K.Diverse roles of the ubiquitin system in NF-κB activation[J].Biochim Biophys Acta，2014，1843（1）：129-136.
|
| [21] |
Maurizi A，Rucci N.The osteoclast in bone metastasis：player and target[J].Cancers（Basel），2018，10（7）：pii：E218.
|
| [26] |
Byun SH，Lee JH，Jung NC，et al.Rosiglitazone-mediated dendritic cells ameliorate collagen-induced arthritis in mice[J].Biochem Pharmacol，2016，115：85-93.
|
| [20] |
Min SY，Yan M，Du Y，et al.Intra-articular nuclear factorκB blockade ameliorates collagen -induced arthritis in mice by elicitingregulatory T cells and macrophages[J].Clin Exp Immunol，2013，172（2）：217-227.
|
| [22] |
Mediero A，Perez-Aso M，Cronstein BN.Activation of adenosine A（2A）receptor reduces osteo-clast formation via PKA and ER K1/2-mediated suppression of NF-κB nuclear translocateion[J].Brit J Pharmacol，2013，169（6）：1372-1388.
|
| [23] |
Issemann I，Green S.Activation of anumber of the steroid receptor superfamily by peroxisome proliferators[J].Nature，1990，347（6294）：645-650.
|
| [24] |
Li Y，Jin D，Xie W，et al.PPAR-γ and Wnt regulate the differentiation of MSCs into adipocytes and osteoblasts respectively[J].Curr Stem Cell Res Ther，2018，13（3）：185-192.
|
| [25] |
Zhang Y，Mao X，Guo Q，et al.Pathway of PPAR-gamma coactivators in thermogenesis：A pivotal traditional Chinese medicine-associated target for individualized treatment of rheumatoid arthritis[J].Oncotarget，2016，7（13）：15 885-15 900.
|
| [27] |
Ormseth MJ，Oeser AM，Cunningham A，et al.Reversing vascular dysfunction in rheumatoid arthritis：improved augmentation index but not endothelial function with peroxisome proliferator-activated receptor γ agonist therapy[J].Arthritis Rheumatol，2014，66（9）：2331-2338.
|
| [28] |
Giles JT，Danielides S，Szklo M，et al.Insulin resistance in rheumatoid arthritis：disease-related indicators and associations with the presence and progression of subclinical atherosclerosis[J].Arthritis Rheumatol，2015，67（3）：626-636.
|
| [29] |
Akune T，Ohba S，Kamekura S，et al.PPAR-γ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors[J].J Clin Invest，2004，113（6）：846-855.
|
| [30] |
Wan Y，Evans RM，Chong LW.PPAR-gamma regulates osteoclastogenesis in mice[J].Nat Med，2007，13（12）：1496-1503.
|
| [31] |
Zou W，Rohatgi N，Chen TH，et al.PPAR-γ regulates pharmacological but not physiological or pathological osteoclast formation[J].Nat Med，2016，22（11）：1203-1205.
|
| [32] |
Zhuang H，Zhang X，Zhu C，et al.Molecular mechanisms of PPAR-γ governing MSC osteogenic and adipogenic differentiation[J].Curr Stem Cell Res Ther，2016，11（3）：255-264.
|
| [33] |
Nencioni A，Wesselborg S，Brossart P.Role of peroxisome proliferator-activated receptor gamma and its ligands in the control of immune responses[J].Crit Rev Immunol，2003，23（1-2）：1-13.
|
| [34] |
Bhat OM，Kumar PU，Rao KR，et al.Terminalia arjuna prevents interleukin-18-induced atherosclerosis via modulation of NF-κB/PPAR-γ mediated pathway in Apo E-mice[J].Inflammopharmacology，2017，26（2）：583-589.
|
| [35] |
贾伟伟，刘春景.类风湿关节炎临床研究进展[J].新疆中医药，2017，35（5）：145-149.
|
